The aim of this preliminary prospective study was to validate the impact of T2D in relation to the on-treatment platelet reactivity in patients with acute ST elevation myocardial infarction (STEMI) treated with ADP receptor blocker therapy. This evidence concerns the gene P2RY1 and ST Elevation Myocardial Infarction.